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Abstract
Schistosomiasis remains a health burden in many parts of the world. The complex life cycle
of Schistosoma parasites and the economic and societal conditions present in endemic
areas make the prospect of eradication unlikely in the foreseeable future. Continued and
vigorous research efforts must therefore be directed at this disease, particularly since only
a single World Health Organization (WHO)-approved drug is available for treatment. The
National Institutes of Health (NIH)–National Institute of Allergy and Infectious Diseases
(NIAID) Schistosomiasis Resource Center (SRC) at the Biomedical Research Institute pro-
vides investigators with the critical raw materials needed to carry out this important
research. The SRC makes available, free of charge (including international shipping costs),
not only infected host organisms but also a wide array of molecular reagents derived from
all life stages of each of the three main human schistosome parasites. As the field of schis-
tosomiasis research rapidly advances, it is likely to become increasingly reliant on omics,
transgenics, epigenetics, and microbiome-related research approaches. The SRC has and
will continue to monitor and contribute to advances in the field in order to support these
research efforts with an expanding array of molecular reagents. In addition to providing
investigators with source materials, the SRC has expanded its educational mission by offer-
ing a molecular techniques training course and has recently organized an international
schistosomiasis-focused meeting. This review provides an overview of the materials and
services that are available at the SRC for schistosomiasis researchers, with a focus on
updates that have occurred since the original overview in 2008.
Background
Schistosomes are parasitic trematodes that cause significant liver, intestinal, and pelvic organ
disease in millions of people living in tropical regions of the world. Infected snails residing in
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freshwater (e.g., rivers, streams, and lakes) transmit the parasites to mammalian hosts. Human
activities conducted within snail-infested waters, e.g., bathing, recreation, and labor, result in
schistosome exposure. Despite decades of environmental control measures as well as mass
drug administration with antihelminthic drugs, schistosomiasis remains endemic in many
regions of sub-Saharan Africa, Brazil, China, and the Philippines. Furthermore, a recent report
describing 11 patients with Schistosoma haematobium infection acquired in Corsica, France,
represents the first schistosomiasis cases in Europe in over 50 years [1]. Praziquantel remains
the only drug that is approved by theWorld Health Organization (WHO) for the treatment of
schistosomiasis, and therefore, the possible emergence of praziquantel-resistant Schistosoma
species needs to be considered. All of these factors illustrate the urgent need for continued
basic and applied research in schistosomiasis, including malacology, parasitology, and drug
and vaccine development efforts. Fortunately, the molecular age of schistosomiasis research is
well underway. Molecular tools to investigate all stages of the Schistosoma life cycle will be criti-
cal to usher in better diagnostics and novel antihelminthic drug and vaccine candidates.
The National Institutes of Health (NIH)–National Institute of Allergy and Infectious Dis-
eases (NIAID)-funded Schistosome Related Reagent Repository (SR3), also known as the
Schistosomiasis Resource Center (SRC) at the Biomedical Research Institute (BRI, Rockville,
Maryland), offers a wide array of materials and support to investigators conducting schistoso-
miasis research, the extent of which those new to the field may be unaware. To enhance the vis-
ibility of the SRC, our predecessors originally highlighted the research reagents and training
available through the center in 2008 [2]. Lewis et al. described the various parasite-derived
products that are available for researchers, the schistosome life cycle training course, bioreposi-
tory activities, and available molecular reagents. Today, the need for the SRC at BRI is keener
than ever.
For instance, scientists studying schistosomiasismust make a substantial commitment to
maintain the parasite’s life cycle, which necessarily involves a mammalian definitive host and
the appropriate species of snail intermediate host. This is often a difficult and expensive com-
mitment to make, particularly in the context of near-flat NIH funding and the already lean
budgets allocated for tropical disease research. Beyond funding challenges, investigators often
face additional problems in the allocation of sufficient lab space to this effort (especially for
snail husbandry) and the limited availability of personnel with schistosome life cycle expertise.
These problems can be especially daunting for the new investigator entering the field and are
compounded in the case of schistosomemolecular biology, since purification of sufficient
amounts of parasite nucleic acids can require a large-scale parasite life cycle. Collectingparasite
and vector molecularmaterials requires expertise, reagents, and equipment that many research
groups do not have. The SRC's molecular resources are a boon to such laboratories. This is par-
ticularly important becausemany labs specialize in a particular aspect of schistosome biology
(such as RNA regulation) and may thus have an acute need for large amounts of only one type
of reagent but little to no need for other reagents.
History, Organization, and Funding
The SRC represents the core business operation of BRI, which is a 501(c) nonprofit research
institute dedicated to researching neglected tropical diseases, particularly schistosomiasis. BRI
houses three divisions: a biological sample repository, a research and development laboratory,
and the SRC. BRI was originally organized in Illinois as the American Foundation for Biologi-
cal Research in 1948 with a focus on cryobiology, before moving to Rockville,Maryland, in
1968 and assuming its current name and research focus. In 1995, BRI received its first award
fromNIH-NIAID to maintain schistosome life cycles for the distribution of reagents to other
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investigators in the field. Prior to the award of this contract to BRI, NIAID had funded a con-
tract for schistosomiasis reagent production at other institutions for decades. The purpose of
these awards was to provide investigators with a renewable and well-characterized source of
standardized reagents for schistosomiasis research. The first such award was won by the Uni-
versity of Michigan in 1967, at which Dr. Yung-san Liang completed his training in schistoso-
miasis. In 1977, the contract was awarded to the University of Massachusetts (U. Mass.) at
Lowell, where Dr. Liang continued his research. In parallel, BRI had an active schistosomiasis
laboratory headed by Dr. Margaret Stirewalt and had beenmaintaining an S.mansoni life cycle
to supply research reagents to investigators at NIH. Dr. Stirewalt trained a number of current
leaders in schistosomiasis research, including Dr. Fred Lewis, who initially joined BRI as one of
her postdoctoral fellows. Years later, Dr. Lewis took over BRI’s schistosomiasis laboratory
upon the retirement of Dr. Stirewalt. Under his direction, BRI was first awarded a schistosomi-
asis contract in 1995, laying the foundation of the current SRC, and has successfully recom-
peted for the contract in 2002 and 2009 (the current award). With that initial award, Dr. Liang
was recruited from U. Mass. at Lowell, bringing with him stocks of S. japonicum and S. haema-
tobium to establish life cycles for these two species and thus expand BRI’s capabilities to
include all three major human schistosomes. Dr. Lewis also recruitedDr. Mathilde (Matty)
Knight, who established a molecular biology laboratory at BRI. In the course of her research,
Dr. Knight initially provided select molecular reagents for other schistosomiasis investigators
upon request using surplus life cycle materials. However, she recognized that the need existed
for a centralized source of well-characterizedmolecular reagents (of known concentration,
purity, restriction enzyme patterns, etc.) and that this would be a logical extension of BRI’s
existing life cycle production work. With this goal in mind, the contract was amended in 2010
to include funding for production of molecular reagents, and thus, the molecular reagent pro-
duction facility was consolidated with the existing life cycle facility then known as the Schisto-
some Related Reagent Repository (SR3). Items were initially distributed directly from the SR3
before the formation of the current partnership with the Biodefense and Emerging Infections
Resources program (BEI Resources, http://www.beiresources.org/) in 2011. The NIH estab-
lished BEI as a central processing entity that allows laboratories to request materials from sev-
eral NIH-funded resource centers, including those for schistosomiasis and malaria research
(Fig 1). In 2014, the SR3 was rebranded as the Schistosomiasis Resource Center (SRC) to reflect
the fact that BEI now served as the repository of molecular reagents and to more accurately
encompass the SRC’s additional activities in education and outreach.
BRI is presently managed by an executive director, Dr. Paul Nisson, and a board of directors
comprised of external scientists and administrative advisors. In 2011, BRI established a scien-
tific advisory committee that convenes two times per year to oversee and advise the SRC on sci-
entific matters. The SRC is currently directed by Dr. Michael Hsieh, who has served as
principal investigator since 2014, and Dr. Margaret Mentink-Kane, who has managed produc-
tion of life cycle and molecular reagents since 2015. Contact information for these and other
key personnel can be found on the BRI website: www.afbr-bri.com/schistosomiasis/contacts.
Financial support of the SRC is provided by the “Maintenance, Development and Production
of Schistosomiasis Parasites, Reagents and Assays” contract administered by the Parasitology
and International Programs Branch (PIPB) of the Division of Microbiology and Infectious Dis-
eases of NIAID (Fig 1). This award supports both the life cycle and molecular work of the SRC.
Available Schistosomiasis Research Materials
Many of the schistosome-specificmolecular tools can be obtained free of charge by scientists
through the SRC. This benefit was made possible because, as detailed above, long before the
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molecular era of schistosomiasis research, the NIH-NIAID had the foresight to establish a
resource from which investigators could obtain various schistosome life stages without having
to expend the effort and funds necessary to maintain Schistosoma spp. life cycles on their own.
Since 2003, the SRC has served as a central facility for the collection and long-term storage of
schistosome and host molecular reagents. At the time of the Lewis et al. publication in 2008,
the SRC molecular product collection, assembled with critical guidance by Dr. Knight, con-
sisted of complementary DNA (cDNA) libraries for S.mansoni and a few reagents (primarily
cDNAs) for Biomphalaria glabrata. It was anticipated at the time that an expanded range of
reagents (cDNA libraries, primers, plasmid DNAs, etc.) would become available for additional
species, and this goal has been fulfilled (Fig 2). These reagents have been duplicated and depos-
ited at BEI for distribution, free of charge, to the scientific community.
As a centralized resource, the NIH-NIAID SRC translated, and continues to translate, into
cost savings for both NIH-NIAID and principal investigators by freeing up staff and infrastruc-
ture costs on grants and allowing investigators to allocate more funds to targeted research
goals. Since October of 2010, the SRC has offeredmolecular reagents free of cost to any labora-
tory. Currently, the SRC has an inventory of over 180 user-ready molecular products, including
total RNA, messenger RNA, enriched poly A mRNA, and cDNA, derived from adult schisto-
somes, eggs, miracidia, and cercariae of the three major human schistosome parasites: S. hae-
matobium, S. japonicum, and S.mansoni, as well as total RNA from S.mansoni (Naval Medical
Research Institute [NMRI] strain) in vitro-transformed sporocysts and schistosomula. The
SRC also offers a large selection of molecular products from Schistosoma intermediate hosts
(Bulinus spp., Oncomelania spp., and Biomphalaria spp.) and a B. glabrata embryonic cell line
Fig 1. An organizational overview of the SRC at BRI. The National Institutes of Health (NIH) funds over
20 institutes and centers, including the National Institute of Allergy and Infectious Diseases (NIAID). NIAID
administers a Resources for Researchers program with a subdivision dedicated to funding the production of
biological materials. Several resources are supported by this mechanism, including the Schistosomiasis
Resource Center (SRC). The SRC (and other resource centers, some omitted for clarity) generates research
reagents that are sent to Biodefense and Emerging Infections (BEI) Resources, which was developed in
2011 to provide a web-based portal to search inventory and facilitate online ordering. Laboratories around
the world interested in studying schistosomiasis are able to obtain SRC-generated reagents through BEI.
doi:10.1371/journal.pntd.0005022.g001
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(designated Bge) that is currently the only mollusk cell line suitable for long-term culture and
genetic manipulation. The SRC has recently expanded its offerings to include an S. haemato-
bium (Egyptian strain) adult worm cDNA library and plasmid vectors containing selected S.
haematobium genes, as well as cDNA synthesized frommicroRNAs (miRNAs) isolated from
the plasma of infected rodent hosts (S. haematobium, S. japonicum, and S.mansoni infections)
(Fig 2). Since 2011, over 300 requests for SRC molecular reagents have beenmade, originating
from 15 countries (Fig 3). In terms of molecular reagents, the most frequently requested catalog
items have included total RNA and genomic DNA derived from adult S.mansoni (NMRI),
genomic DNA from adult S. haematobium, and total RNA from S.mansoni (NMRI) cercaria
and eggs. For life cycle reagents, the highest-demand items continue to be S.mansoni (NMRI)-
exposedB. glabrata snails and mice, as well as unexposedB. glabrata (NMRI) snails. Also fre-
quently requested are Bulinus truncatus snails exposed to S. haematobium and B. glabrata
snails exposed to S.mansoni (PR-1 strain).
Fig 2. Schematic of molecular materials available from BEI Resources. A variety of molecular materials derived from all life stages of three
Schistosoma species (S. mansoni, S. haematobium, and S. japonicum) and infected host species are available as indicated. Items 10, 11, and 12 are
future products.
doi:10.1371/journal.pntd.0005022.g002
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How to Apply for Materials
Because of the importance of the SRC’s mission, investigators at an array of institutions and
organizations are eligible to receive materials: academic, nonprofit, industry, and government
(local and national, worldwide). Investigators wishing to obtain SRC-generated schistosomiasis
research reagents are referred to the BEI website (www.beiresources.org/).Here, prospective
users must first register as a Biosafety Level 1 or 2 registrant, depending upon the materials
they intend to use. BEI provides forms that can be downloaded directly from the website (S1
File). These forms allow the registrant to submit the following information: Registrant Applica-
tion, Material Transfer Agreement, Biographical Sketch, and Biosafety Level 2 checklist for the
facility that will be receiving the material. Upon receipt of all required forms, BEI will inform
the registrant that his or her application is complete, and she or he will have the opportunity to
Fig 3. The geographic locations of requests for SRC-generated molecular reagents from 2011–2016. Requests for SRC-
generated molecular reagents have come from 15 countries over the years 2011 through July 2016. Shown is the percentage of
total requests attributable to each country. The United States as a whole accounts for 66.7% of all items ordered, distributed as
shown among the Northeast (Washington, D.C., Massachusetts, Maryland, New York, and Pennsylvania), South (Alabama,
Georgia, Texas, and Virginia), Midwest (Iowa, Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin), and West
(California, Colorado, New Mexico, and Utah).
doi:10.1371/journal.pntd.0005022.g003
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create a profile for logging in to the website. The new user can then refer to the BEI catalog for
a complete listing of all available reagents, each of which are assigned a catalog number. Avail-
able items can be browsed by resource/disease area, depositor (such as the SR3), or organism.
Users can also search by specific catalog number (if known) or key words. Each item has a
product sheet (describing the material, its origin, and the methods used for its production) and
a certificate of analysis with lot-specific information such as concentration and purity. The
user can then add an item or items of interest to his or her online cart, review the order, and
submit it as with any typical vendor.
To properly attribute the valuable funding that allows the SRC to fulfill its mission, NIAID
asks that users acknowledge this fact in any publication that results from SRC-generated mate-
rials. To that end, materials should be acknowledged as such: “[reagent provided: e.g., B. glab-
rata snails] provided by the NIAID Schistosomiasis Resource Center of the Biomedical
Research Institute (Rockville,MD) through NIH-NIAID contract HHSN2722010000051 for
distribution through BEI Resources.”
Complementary Resources
To promote schistosomiasis research, we wish to direct the reader to molecular resources out-
side of our center that are nonetheless valuable and potentially complementary to SRC
reagents. A comprehensive resource for genomic information on a wide variety of nematode
and platyhelminth species, including seven Schistosoma species, can be found at WormBase
ParaSite (http://parasite.wormbase.org/). An updated version of the Schistosoma genome data-
base (SchistoDB) is available via http://SchistoDB.net. This integrated website provides the lat-
est genomic sequence and annotation data for S. haematobium, S. japonicum, and S.mansoni
[3]. Since the publication of our original SRC overview in 2008, the ensuing years have seen the
publication of the genomes for all three major human schistosome species [4–6], with addi-
tional genomic and transcriptomic data for S.mansoni in particular [7]. The subsequent publi-
cation of a genomic linkage map for S.mansoni, the first for a helminth species [8], has allowed
for further research probing the basis of drug (oxamniquine) resistance by classical linkage
mapping techniques [9] and by more efficientmethods such as exome capture and extreme
quantitative trait locus analysis [10]. Host tissue transcriptomes have been characterized for
the mouse bladder following S. haematobium egg exposure as well as for the liver and spleen
following S. japonicum infection [11–15]. Next-generation sequencing (NGS) has been utilized
to identify genes under selective pressure in S.mansoni and has aided in the search for new
molluscicide formulations against Oncomelania hupensis [16,17]. Furthermore, since the first
report of particle bombardment to transfect adult worms [18], other groups have continued to
advance schistosome transgenics: in 2012, Rinaldi et al. described germline transmission of a
transgene introduced into parasite eggs via murine leukemia virus [19,20]. The understanding
of epigenetic regulation in lower organisms is advancing as molecular tools become available to
examine invertebrate epigenetics including B. glabrata and Schistosoma [21,22]. Clinical stud-
ies have shown that modification of the host genome occurs following infectionwith S. haema-
tobium [23–25], and deeper studies are much needed in this area. Similarly, the influence of
the microbiome (both host and parasite) on schistosomiasis infection is only beginning to be
explored. Recent studies have demonstrated that infectionwith the liver flukeOpisthorchis
viverrini alters the makeup and distribution of the microbiome in an animal model [26] and
that differences exist in the fecal microbiome of humans infected versus uninfectedwith S. hae-
matobium [27]. Another recent report characterized the microbiome of B. glabrata [28]. Thus,
schistosome-related omics research is thriving, which will drive continued and expanded need
for SRC reagents.
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Education and Outreach
In addition to supplying a variety of reagents to the community, in 2012 the SRC began offer-
ing a hands-on annual course to introduce students, postdoctoral fellows, and investigators to
fundamental molecular techniques that are useful for schistosomiasis research. This course is
offered in addition to the ongoing training courses dedicated to the schistosome life cycle and
thus represents an expansion of the SRC’s educational mission. For both courses, enrollment is
capped (at 5–6 for the molecular course or up to 10 for the life cycle) in order to maximize the
ability of students to interact closely with SRC staff and invited speakers. Applications are not
required, but attendees must notify the SRC of their intent to attend so that a position can be
reserved.Courses are typically organized in the spring (life cycle) and fall (life cycle and molec-
ular), with the exact dates being announced 2–3 months prior on the BRI website. Announce-
ments are also distributed directly to the SRC client list via email. For both courses, the rosters
have included a mix of individuals at all academic levels: graduate students, technicians, post-
doctoral fellows, scientists, and senior investigators. Sample course outlines for both the life
cycle and the molecular course are included as a supplemental file (S2 File). The newmolecular
course is offered free of charge to the research community and features important techniques
such as gene knockdown in snails and schistosome parasites by double-stranded RNA
(dsRNA) (synthesized in-house) and miRNA. The course has also taught attendees polyethyle-
nimine-based techniques for transfection of target cells and organisms with dsRNA, reporter
miRNA, and plasmid vectors. This topic in particular illustrates the immediate success of the
molecular course. Attendees from the 2012 course, Shuang Liang and Emmitt Jolly, published
a manuscript based on the techniques developed in the class [29]. While some general tech-
niques have recurred in multiple courses, the overall focus varies from year to year as the SRC
seeks to offer cutting-edge topics that track the current interests of the field. In 2015, the course
theme was the epigenetics of the intermediate host snail. These courses are valuable beyond
generating publications, since insights are shared regarding which molecular reagents work
best with invertebrate startingmaterial. Lectures are given by SRC staff and invited external
speakers and cover a range of relevant topics, including miRNA gene regulationmechanisms,
DNA methylation, and schistosome-specificbioinformatics. Hands-on laboratory exercises
have involved nucleic acid purification and quality assurance, cDNA synthesis, gene transfec-
tion, gene transcription quantification, and measurement of DNA methylation in schistosome
parasites and/or snails. Finally, the SRC-BRI website offers a comprehensive array of standard
operating procedures for parasite and host speciesmaintenance and molecular protocols that
are a valuable resource for the schistosomiasis research community (www.afbr-bri.com/
schistosomiasis/standard-operating-procedures/).
The Symposium for International Research and Innovations in
Schistosomiasis
The SRC will continue to track and contribute to developments in the field of schistosomiasis
and in infectious disease research in general, in order to meet the changing needs of the
research community and expand the scope of the reagents offered, with a recent emphasis on
molecular reagents. In fact, the SRC at BRI has taken a leading role in fostering advances in
schistosomiasis research. In 2016, BRI and the GeorgeWashington University (Washington,
D.C.) collaborated to sponsor an international meeting intended as one of the first of its kind
that will focus solely on schistosomiasis research: the Symposium for International Research
and Innovations in Schistosomiasis (SIRIS). The 2016 meeting, “Defining the Global Impact of
Schistosomiasis,” brought together 70 attendees. Experts from a variety of academic, industry,
and private organizations presented their latest findings, ranging from an epidemiological level
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to a molecular level, on topics including the effectiveness of current therapeutic strategies, mass
drug administration efforts, parasite biology, vaccines, omics, and disease pathology. Given the
overwhelmingly positive feedback gathered from attendees, this event promises to become a
key forum for the exchange of ideas in the schistosomiasis research community for years to
come. Through efforts such as these, the SRC at BRI will continue to fulfill its mission of
enabling the research community to combat schistosomiasis.
Key Learning Points
• Schistosomiasis remains a major health burden in many parts of the world, and contin-
ued research efforts are critical.
• The SRC provides investigators with a wide variety of parasite- and host-derived raw
materials and has fulfilledover 300 requests since 2011.
• The SRC partneredwith BEI in 2011 to streamline the inventory and shipping of the
more than 180 products now available.
• Rapid advances in schistosomiasis research, such as the recently completed SchistoDB
genome database, point to an increasingly molecular focus for the field.
• The SRC has instituted a molecular techniques training course to complement its exist-
ing life cycle course, now offers numerous molecular reagents, and recently hosted an
international schistosomiasis-focused scientificmeeting.
Top Five Papers in the Field
1. Young ND, Jex AR, Li B, Liu S, Yang L, Xiong Z, et al. Whole-genome sequence of
Schistosoma haematobium. Nat Genet. 2012 Jan 15;44(2):221–5. doi:10.1038/ng.1065.
2. Zhou Y, Zheng H, Chen X, Zhang L,Wang K, Guo J, et al. The Schistosoma japonicum
genome reveals features of host-parasite interplay. Nature. 2009 Jul 16; 460
(7253):345–351. doi:10.1038/nature08140.
3. BerrimanM, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, CergueiraGC, et al. The
genome of the blood fluke Schistosoma mansoni. Nature. 2009 Jul 16;460(7253):352–
8. doi:10.1038/nature08160.
4. Rinaldi G, Eckert SE, Tsai IJ, Suttiprapa S, Kines KJ, Tort JF, et al. Germline transgen-
esis and insertionalmutagenesis in Schistosoma mansoni mediated by murine leuke-
mia virus. PLoS Pathog. 2012;8:16. doi:10.1371/journal.ppat.1002820.
5. Cai P, Gobert GN, You H, McManus DP. The Tao survivorship of schistosomes:
Implications for schistosomiasis control. Int J Parasitol. 2016 Feb 9. pii: S0020-7519
(16)00023-0. doi: 10.1016/j.ijpara.2016.01.002.
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Supporting Information
S1 File. BEI registration forms. Investigators wishing to use SRC-generated life cycle and
molecular reagents must first register on the BEI website. Included are blank registration forms
for Biosafety Level 1 and 2 laboratories.
(PDF)
S2 File. Course outlines for the SRC’s life cycle and molecular training courses.The SRC at
BRI offers a life cycle course twice yearly and an annual molecular skills course. Included are
example outlines for each course.While the life cycle course features recurring but continually
refined content, the molecular course topic is changed yearly to track updates in the field.
(PDF)
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